Journal of Vascular Surgery
Volume 50, Issue 1 , Pages 54-60 , July 2009

National trends in lower extremity bypass surgery, endovascular interventions, and major amputations

Presented at the New England Society for Vascular Surgery, Newport, RI, October 3-5, 2008.

  • Philip P. Goodney, MD, MS

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • VA Outcomes Group, White River Junction, Vt
    • Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, NH
    • Corresponding Author InformationReprint requests: Philip P. Goodney, MD, Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03765
    • ,
  • Adam W. Beck, MD

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH
    • ,
  • Jan Nagle, MS, RPh

      Affiliations

    • JLM Data, Inc., Chicago, Ill
    • ,
  • H. Gilbert Welch, MD, MPH

      Affiliations

    • VA Outcomes Group, White River Junction, Vt
    • Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Hanover, NH
    • ,
  • Robert M. Zwolak, MD, PhD

      Affiliations

    • Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Received 5 November 2008 ,Accepted 9 January 2009.

References 

  1. McDermott MM. The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med. 2006;73(Suppl 4):S2–S7
  2. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study (The Cardiovascular Health Study Group). Arterioscler Thromb Vasc Biol. 1999;19:538–545
  3. Nowygrod R, Egorova N, Greco G, Anderson P, Gelijns A, Moskowitz A, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg. 2006;43:205–216
  4. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45:1185–1191
  5. TASC II Working GroupNorgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67
  6. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg. 2004;39:1200–1208
  7. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934
  8. Hynes N, Mahendran B, Manning B, Andrews E, Courtney D, Sultan S. The influence of subintimal angioplasty on level of amputation and limb salvage rates in lower limb critical ischaemia: a 15-year experience. Eur J Vasc Endovasc Surg. 2005;30:291–299
  9. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745–2749
  10. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med. 1991;325:556–562
  11. Center for Medicare and Medicaid Services Website. www.cms.govAccessed July 18, 2008
  12. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J, Stanley AC, Nolan BW VSGNNE. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg. 2007;46:1093–1101discussion 1101-2
  13. American Medical Association Website. www.ama-assn.orgAccessed July 17, 2008
  14. Dillingham TR, Pezzin LE, Mackenzie EJ. Racial differences in the incidence of limb loss secondary to peripheral vascular disease: a population-based study. Arch Phys Med Rehabil. 2002;83:1252–1257
  15. Dillingham TR, Pezzin LE, MacKenzie EJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875–883
  16. Keeling WB, Stone PA, Armstrong PA, Kearney H, Klepczyk L, Blazick E, et al. Increasing endovascular intervention for claudication: impact on vascular surgery resident training. J Endovasc Ther. 2006;13:507–513
  17. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701–710
  18. Hirsch AT. Treatment of peripheral arterial disease–extending “intervention” to “therapeutic choice”. N Engl J Med. 2006;354:1944–1947
  19. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–e654
  20. Vascular Surgery. In:  Rutherford RB editors. Textbook of Vascular Surgery. 2006;
  21. Nolan B, Finalyson S, Tosteson A, Powell R, Cronenwett J. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease--decision analysis. J Vasc Surg. 2007;45:1179–1184
  22. Society of Vascular Surgery Website. www.vascularweb.orgAccessed October 2, 2008
  23. Weaver FA, Hood DB, Shah H, Alexander J, Katz S, Rowe V, et al. Current guidelines produce competent endovascular surgeons. J Vasc Surg. 2006;43:992–998; discussion 998
  24. Allie DE, Hebert CJ, Lirtzman MD, et al. A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome. J Invasive Cardiol. 2005;17:427–432
  25. Dartmouth Atlas Cardiovascular and Thoracic Healthcare Health Care: Manning Selvage & Lee. 1998;
  26. Simon RW, Simon-Schulthess A, Amann-Vesti BR. Intermittent claudication. BMJ. 2007;334:746
  27. Taylor SM, Kalbaugh CA, Blackhurst DW, Cass AL, Trent EA, Langan EM, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg. 2006;44:747–755; discussion 755-6
  28. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114:688–699
  29. Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg. 2008;47:774–781
  30. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42:456–464; discussion 464-5
  31. CAPRIE Steering Committee. [No authors listed] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  32. White CJ, Gray WA. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation. 2007;116:2203–2215
  33. Al-Omran M, Tu JV, Johnston KW, Mamdani MM, Kucey DS. Use of interventional procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study. J Vasc Surg. 2003;38:289–295
  34. Ho V, Wirthlin D, Yun H, Allison J. Physician supply, treatment, and amputation rates for peripheral arterial disease. J Vasc Surg. 2005;42:81–87
  35. Ballard JL, Bergan JJ, Singh P, Yonemoto H, Killeen JD. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg. 1998;28:94–101; discussion 101-3
  36. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007;45:10–16; discussion 16
  37. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–751; discussion 751
  38. Iezzoni LI. The risks of risk adjustment. JAMA. 1997;278:1600–1607
  39. Hall BL, Hirbe M, Waterman B, Boslaugh S, Dunagan WC. Comparison of mortality risk adjustment using a clinical data algorithm (American College of Surgeons National Surgical Quality Improvement Program) and an administrative data algorithm (Solucient) at the case level within a single institution. J Am Coll Surg. 2007;205:767–777
  40. Dimick JB, Birkmeyer JD. Ranking hospitals on surgical quality: does risk-adjustment always matter?. J Am Coll Surg. 2008;207:347–351
  41. Stukel TA, Fisher ES, Wennberg DE. Using observational data to estimate treatment effects. JAMA. 2007;297:2078–2079; author reply 2079

 Competition of interest: none.

PII: S0741-5214(09)00054-8

doi: 10.1016/j.jvs.2009.01.035

Journal of Vascular Surgery
Volume 50, Issue 1 , Pages 54-60 , July 2009

Article Tools

* Image Usage & Resolution